Clinical Scorecard: Exploring the Social Determinants of Health in Psoriasis Patients of Diverse Racial and Ethnic Backgrounds in the United States

At a Glance

Key Highlights

• Participants from Black/African American and Hispanic/Latino backgrounds reported more barriers to healthcare access.
• Quality of life impacts were high across all racial and ethnic groups.
• Financial burden and trust in healthcare providers varied among different populations.
• Need for culturally sensitive and financially accessible care was emphasized.
• Digital resources for disease management require enhancement for better accessibility.

Guideline-Based Recommendations

Diagnosis

• Self-reported diagnosis of psoriasis by a medical professional is required.

Management

• Mild cases treated with topical therapies; moderate-to-severe cases may require systemic agents and biologics.

Monitoring & Follow-up

• Monitoring of disease severity and treatment response is essential.

Risks

• Access disparities due to high costs, insurance restrictions, and implicit biases.

Patient & Prescribing Data

Adults aged ≥ 18 years with a self-reported diagnosis of psoriasis.

Biologic therapies are recommended as first-line systemic treatments for moderate-to-severe psoriasis.

Clinical Best Practices

• Integrate patient-centered support systems into clinical practice.
• Address systemic and cultural factors affecting patient experiences.
• Foster cultural humility and promote health equity in healthcare delivery.

Related Resources & Content

• Study on Psoriasis